Healthy
Conditions
Keywords
plasma volume, technetium-labeled albumin, radioiodine-labeled albumin, Healthy volunteers
Brief summary
The purpose of the present study is to compare plasma volume determination by 99mTc-labeled albumin with 125I-labeled albumin. Fifteen subjects will be enrolled. The hypothesis is that plasma volume determined by the different methods are the same.
Detailed description
For many years, radioiodinated albumin has been the golden standard for measurement of plasma volume. There are a number of clinical situations in which a nuclide with a shorter half-life would be preferred. Furthermore, due to periodic lapses in the availability in the delivery of 125I-labeled albumin, there is a need to evaluate another nuclide as a tracer for plasma volume determination. 99mTc-labeled albumin is easily prepared by a simple and reproducible method with a high labeling efficiency and short half-life. In this study, we want to compare plasma volume determined by 99mTc-labeled albumin with plasma volume determined by 125I-albumin (golden standard). In both procedures, plasma volume is estimated from multiple postinjection samples for accurate zero-time extrapolation in order to correct for leakage of labeled albumin from the vascular compartment.
Interventions
The test is performed using 5MBq technetium-labeled albumin (99mTc-albumin-Vasculosis) with several postinjection samples for accurate zero-time extrapolation.
The test is performed using 0.2MBq 125iodine-labeled albumin (125I-albumin) with several postinjection samples for accurate zero-time extrapolation.
Sponsors
Study design
Eligibility
Inclusion criteria
* BMI \< 27 kg/m2 * Written informed consent
Exclusion criteria
* Hypertension (140/90 mmHg) * Diabetes mellitus * Any use of medication * Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma volume determined by 99mTc-labeled albumin and 125I-labeled albumin | January 2011 |
Secondary
| Measure | Time frame |
|---|---|
| Rates of loss of 99mTc-labeled albumin and 125I-labeled albumin from the circulation | January 2011 |
Countries
Denmark